Study: AI-genomics synergy for drug repurposing in breast cancer: an interpretability-driven framework. Image Credit: ProStockStudio / Shutterstock In a recent review published in the journal npj ...
Women with abnormal mammograms often have to wait for weeks to find out whether they have breast cancer. Now, researchers at UC San Francisco and UC Berkeley have found a way to help reduce the wait ...
Zacks Investment Research on MSN
RDNT's unit DeepHealth expands AI breast suite with FDA-cleared tools
DeepHealth, a wholly owned subsidiary of RadNet RDNT, recently received FDA clearances for two new functionalities within its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results